251
Views
1
CrossRef citations to date
0
Altmetric
Articles

Treatment effect on ordinal functional outcome using piecewise multistate Markov model with unobservable baseline: an application to the modified Rankin scale

, , , , &
Pages 82-97 | Received 11 May 2017, Accepted 14 Apr 2018, Published online: 09 Jul 2018

References

  • Aalen, O. O., Farewell, V., De Angelis, D., Day, N., Gill, O. (1997). A Markov model for HIV disease progression including the effect of HIV diagnosis and treatment: Application to AIDS prediction in England and Wales. Statistics in Medicine 16(19):2191–2210.
  • Adams, H. P., Davis, P. H., Leira, E. C., Chang, K.-C., Bendixen, B. H., Clarke, W. R., Woolson, R. F., Hansen, M. D. (1999). Baseline NIH Stroke Scale score strongly predicts outcome after stroke: A report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Neurology 53(1):126. doi:10.1212/WNL.53.1.126
  • Agresti, A. (1999). Modelling ordered categorical data: Recent advances and future challenges. Statistics in Medicine 18(17–18):2191–2207.
  • Bruno, A., Saha, C., Williams, L. S. (2009). Percent change on the National Institutes of Health Stroke Scale: A useful acute stroke outcome measure. Journal of Stroke and Cerebrovascular Diseases: The Official Journal of National Stroke Association 18(1):56–59. doi:10.1016/j.jstrokecerebrovasdis.2008.09.002
  • Capes, S. E., Hunt, D., Malmberg, K., Pathak, P., Gerstein, H. C. (2001). Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients. A Systematic Overview 32(10):2426–2432.
  • Cassarly, C., Martin, R. H., Chimowitz, M., Peña, E. A., Ramakrishnan, V., Palesch, Y. Y. (2017a). Assessing Type I error and power of multistate Markov models for panel data—A simulation study. Communications in Statistics - Simulation and Computation 46(9):7040–7061. doi:10.1080/03610918.2016.1222425
  • Cassarly, C., Martin, R. H., Chimowitz, M., Peña, E. A., Ramakrishnan, V., Palesch, Y. Y. (2017b). Comparison of multistate Markov modeling with contemporary outcomes in a reanalysis of the NINDS tissue plasminogen activator for acute ischemic stroke treatment trial. PLOS ONE 12(10):e0187050. doi:10.1371/journal.pone.0187050
  • Chaisinanunkul, N., Adeoye, O., Lewis, R. J., Grotta, J. C., Broderick, J., Jovin, T. G., Nogueira, R. G., Elm, J. J., Graves, T., Berry, S., Lees, K. R., Barreto, A. D., Saver, J. L., Furlan, A., Baxter, B., Lutsep, H. L., Ribo, M., Jansen, O., Gupta, R., Pereira, V. M. (2015). Adopting a patient-centered approach to primary outcome analysis of acute stroke trials using a utility-Weighted Modified Rankin Scale. Stroke: A Journal of Cerebral Circulation 46(8):2238–2243. doi:10.1161/STROKEAHA.114.008547
  • Chiang, C. L. (1980). An Introduction to Stochastic Processes and Their Applications. New York: Robert E. Krieger Publishing.
  • DiStefano, C., Zhu, M., Mîndrilă, D. (2009). Understanding and using factor scores: Considerations for the applied researcher. Practical Assessment, Research & Evaluation. 14(20).
  • DeSantis, S. M., Lazaridis, C., Palesch, Y., Ramakrishnan, R. (2014). Regression analysis of ordinal stroke clinical trial outcomes: An application to the NINDS t-PA trial. International Journal of Stroke : Official Journal of the International Stroke Society 9(2):226–231. doi:10.1111/ijs.12052
  • Feng, W., Vasquez, G., Suri, M. F. K., Lakshminarayan, K., Qureshi, A. I. (2011). Repeated-measures analysis of the National Institute of Neurological Disorders and stroke rt-PA stroke trial. Journal of Stroke and Cerebrovascular Diseases: The Official Journal of National Stroke Association 20(3):241–246. doi:10.1016/j.jstrokecerebrovasdis.2010.01.003
  • Ginsberg, M. D., Palesch, Y. Y., Hill, M. D. (2006). The ALIAS (ALbumin In Acute Stroke) phase III randomized multicentre clinical trial: Design and progress report. Biochemical Society Transactions 34(6):1323–1326. doi:10.1042/BST0341323
  • Ginsberg, M. D., Palesch, Y. Y., Hill, M. D., Martin, R. H., Moy, C. S., Barsan, W. G., Waldman, B. D., Tamariz, D., Ryckborst, K. J. (2013). High-dose albumin treatment for acute ischaemic stroke (ALIAS) part 2: A randomised, double-blind, phase 3, placebo-controlled trial. The Lancet Neurology 12(11):1049–1058. doi:10.1016/S1474-4422(13)70223-0
  • Hill, M. D., Demchuk, A. M., Goyal, M., Jovin, T. G., Foster, L. D., Tomsick, T. A., Von Kummer, R., Yeatts, S. D., Palesch, Y. Y., Broderick, J. P. (2014). Alberta stroke program early computed tomography score to select patients for endovascular treatment. Interventional Management of Stroke (IMS)-III Trial 45(2):444–449.
  • Hill, M. D., Martin, R. H., Palesch, Y. Y., Tamariz, D., Waldman, B. D., Ryckborst, K. J., Moy, C. S., Barsan, W. G., Ginsberg, M. D. (2011). The albumin in acute stroke part 1 trial. An Exploratory Efficacy Analysis 42(6):1621–1625.
  • Jackson, C. (2011). Multi-state models for panel data: The msm package for R. Journal of Statistical Software 38(8). doi:10.18637/jss.v038.i08
  • Jackson, C. (2016). Multi-State Modelling With R: The Msm Package. Cambridge, UK: MRC Biostatistics Unit.
  • Jennett, B., Bond, M. (1975). Assessment of outcome after severe brain damage. Lancet 305:480–484. doi:10.1016/S0140-6736(75)92830-5
  • Keiding, N., Klein, J. P., Horowitz, M. M. (2001). Multi-state models and outcome prediction in bone marrow transplantation. Statistics in Medicine 20(12):1871–1885. doi:10.1002/sim.810
  • Knoflach, M., Matosevic, B., Rücker, M., Furtner, M., Mair, A., Wille, G., Zangerle, A., Werner, P., Ferrari, J., Schmidauer, C., Seyfang, L., Kiechl, S., Willeit, J. (2012). Functional recovery after ischemic stroke—A matter of age. Data from the Austrian Stroke Unit Registry 78(4):279–285.
  • Lyden, P., Brott, T., Tilley, B., Welch, K. M. A., Mascha, E. J., Levine, S., Haley, E. C., Grotta, J., Marler, J., Group, N. T. S. S. (1994). Improved reliability of the NIH Stroke Scale using video training. Stroke: A Journal of Cerebral Circulation 25:2220–2226.
  • Mahoney, F. I., Barthel, D. W. (1965). Functional evaluation: The Barthel index. Maryland State Medical Journal 14:61–65.
  • Marshall, G., Jones, R. H. (1995). Multi-state models and diabetic retinopathy. Statistics in Medicine 14(18):1975–1983.
  • Martin, R. H., Yeatts, S. D., Hill, M. D., Moy, C. S., Ginsberg, M. D., Palesch, Y. Y. (2016). ALIAS (Albumin in Acute Ischemic Stroke) Trials. Analysis of the Combined Data from Parts 1 and 2 47(9):2355–2359.
  • Newby, L. K., Rutsch, W. R., Califf, R. M., Simoons, M. L., Aylward, P. E., Armstrong, P. W., Woodlief, L. H., Lee, K. L., Topol, E. J., Van De Werf, F. (1996). Time from symptom onset to treatment and outcomes after thrombolytic therapy. Journal of the American College of Cardiology 27(7):1646–1655.
  • Palesch, Y. Y., Yeatts, S. D., Tomsick, T. A., Foster, L. D., Demchuk, A. M., Khatri, P., Hill, M. D., Jauch, E. C., Jovin, T. G., Yan, B., Von Kummer, R., Molina, C. A., Goyal, M., Schonewille, W. J., Mazighi, M., Engelter, S. T., Anderson, C., Spilker, J., Carrozzella, J., Ryckborst, K. J., Janis, L. S., Simpson, A., Simpson, K. N., Broderick, J. P. (2015). Twelve-month clinical and quality-of-life outcomes in the interventional management of stroke III trial. Stroke: A Journal of Cerebral Circulation 46(5):1321–1327. doi:10.1161/STROKEAHA.115.009180
  • Pérez-Ocón, R., Ruiz-Castro, J. E., Gámiz-Pérez, M. L. (2001). Non-homogeneous Markov models in the analysis of survival after breast cancer. Journal of the Royal Statistical Society: Series C (Applied Statistics) 50(1):111–124. doi:10.1111/1467-9876.00223
  • Pexman, J. H. W., Barber, P. A., Hill, M. D., Sevick, R. J., Demchuk, A. M., Hudon, M. E., Hu, W. Y., Buchan, A. M. (2001). Use of the Alberta Stroke Program Early CT Score (ASPECTS) for assessing CT scans in patients with acute stroke. American Journal of Neuroradiology 22(8):1534–1542.
  • Price, M., Hertzberg, V., Wright, D. W. (2013). Does the sliding dichotomy result in higher powered clinical trials for stroke and traumatic brain injury research? Clinical Trials 10(6):924–934. doi:10.1177/1740774512458601
  • Roozenbeek, B., Lingsma, H. F., Perel, P., Edwards, P., Roberts, I., Murray, G. D., Maas, A. I. R., Steyerberg, E. W. (2011). The added value of ordinal analysis in clinical trials: An example in traumatic brain injury. Critical Care 15(3). doi:10.1186/cc10324
  • Sankey, S. S., Weissfeld, L. A. (1998). A study of the effect of dichotomizing ordinal data upon modeling. Communications in Statistics: Simulation and Computation 27(4):871–887. doi:10.1080/03610919808813515
  • Saver, J. L. (2007). Novel end point analytic techniques and interpreting shifts across the entire range of outcome scales in acute stroke trials. Stroke: A Journal of Cerebral Circulation 38(11):3055–3062. doi:10.1161/STROKEAHA.107.488536
  • Savitz, S. I., Lew, R., Bluhmki, E., Hacke, W., Fisher, M. (2007). Shift analysis versus dichotomization of the modified rankin scale outcome scores in the NINDS and ECASS-II trials. Stroke: A Journal of Cerebral Circulation 38(12):3205–3212. doi:10.1161/STROKEAHA.107.489351
  • Smycka, J., Keil, P. (2015). Bayesian PCA. Retrieved from http://www.petrkeil.com/?p=2316
  • Stevens, J.P. (2009). Applied Multivariate Statistics for the Social Sciences. New York: Taylor & Francis Group.
  • The National Institute of Neurological Disorders Stroke rt-PA Stroke Study Group. (1995). Tissue plasminogen activator for acute ischemic stroke. The New England Journal of Medicine 333(24):1581–1588. doi:10.1056/NEJM199512143332401
  • The Optimising Analysis of Stroke Trials (OAST) Collaboration. (2007). Can we improve the statistical analysis of stroke trials? Statistical reanalysis of functional outcomes in stroke trials. Stroke: A Journal of Cerebral Circulation 38(6):1911–1915. doi:10.1161/STROKEAHA.106.474080
  • Tilley, B. C., Marler, J., Geller, N. L., Lu, M., Legler, J., Brott, T., Lyden, P., Grotta, J. (1996). Use of a global test for multiple outcomes in stroke trials with application to the National Institute of Neurological Disorders and Stroke t-PA stroke trial. Stroke: A Journal of Cerebral Circulation 27(11):2136–2142.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.